2013•Zhongguo shengwuzhipinxue zazhiRequires access

Construction and identification of recombinant adenovirus with COX-2-shRNA

Zhiguang Tu

Open publisher page 1 citations

Abstract

Objective To construct and identify the recombinant adenovirus with a short hairpin RNA(shRNA)targeting cyclooxygenase-2(COX-2),with a tag of enhanced green fluorescent protein(EGFP),and observe its effect on the proliferation of liver cancer SMMC-7721 cells.Methods The U6 expression promoter and shRNA sequences of previously constructed eukaryotic expression vector pGenesil-1-COX-2-shRNA and negative control plasmid pGenesil-1HK were subcloned into adenovirus shuttle plasmid pAdTrack.The constructed recombinant adenovirus shuttle plasmids pAdTrack-U6-COX-2-shRNA-EGFP and pAdTrack-U6-HK-EGFP were identified by enzyme digestion and DNA sequencing,then linearized with Pme Ⅰ and transformed to competent AdEasier.The obtained recombinant adenovirus plasmids pAd-U6-COX-2-shRNA-EGFP and pAd-U6-HK-EGFP were linearized with PacⅠ and transfected to AD293 cells for packaging.The obtained recombinant adenoviruses Ad-U6-COX-2-shRNA-EGFP and Ad-U6-HK-EGFP were subjected to three cycles of amplification and determined for titer.The mRNA transcription and protein expression of COX-2 in infected cells were determined by RT-PCR and Western blot.The effect of Ad-U6-COX-2-shRNA-EGFP on proliferation of SMMC-7721 cells was observed by MTS method.Results Recombinant adenovirus shuttle plasmids pAdTrack-U6-COX-2-shRNA-EGFP and pAdTrack-U6-HK-EGFP,as well as recombinant adenovirus plasmids pAd-U6-COX-2-shRNAEGFP and pAd-U6-HK-EGFP,were constructed correctly as proved by enzyme digestion and sequencing,and successfully transfected to AD293 cells.The titers of recombinant adenoviruses Ad-U6-COX-2-shRNA-EGFP and Ad-U6-HK-EGFP were 1.4 × 10 12 and 2.0 × 10 12 pfu / ml respectively.The mRNA transcription and protein expression of COX-2 as well as proliferation ability of SMMC-7721 cells infected with Ad-U6-COX-2-shRNA-EGFP were significantly lower than those in blank and negative control groups(both P 0.05).Conclusion Recombinant adenovirus Ad-U6-COX-2-shRNA-EGFP was constructed successfully,which inhibited the proliferation of SMMC-7721 cells significantly.The study solved the problems in clinical application and laid a foundation of research on therapy of liver cancer as well as the relevant molecular mechanism.

About this research paper

What this paper is about

Objective To construct and identify the recombinant adenovirus with a short hairpin RNA(shRNA)targeting cyclooxygenase-2(COX-2),with a tag of enhanced green fluorescent protein(EGFP),and observe its effect on the proliferation of liver cancer SMMC-7721 cells.Methods The U6 expression promoter and shRNA sequences of previously constructed eukaryotic expression vector pGenesil-1-COX-2-shRNA and negative control plasmid pGenesil-1HK were subcloned into adenovirus shuttle plasmid pAdTrack.The constructed recombinant adenovirus shuttle plasmids pAdTrack-U6-COX-2-shRNA-EGFP and pAdTrack-U6-HK-EGFP were identified by enzyme digestion and DNA sequencing,then linearized with Pme Ⅰ and transformed to competent AdEasier.The obtained recombinant adenovirus plasmids pAd-U6-COX-2-shRNA-EGFP and pAd-U6-HK-EGFP were linearized with PacⅠ and transfected to AD293 cells for packaging.The obtained recombinant adenoviruses Ad-U6-COX-2-shRNA-EGFP and Ad-U6-HK-EGFP were subjected to three cycles of amplification and determined for titer.The mRNA transcription and protein expression of COX-2 in infected cells were determined by RT-PCR and Western blot.The effect of Ad-U6-COX-2-shRNA-EGFP on proliferation of SMMC-7721 cells was observed by MTS method.Results Recombinant adenovirus shuttle plasmids pAdTrack-U6-COX-2-shRNA-EGFP and pAdTrack-U6-HK-EGFP,as well as recombinant adenovirus plasmids pAd-U6-COX-2-shRNAEGFP and pAd-U6-HK-EGFP,were constructed correctly as proved by enzyme digestion and sequencing,and successfully transfected to AD293 cells.The titers of recombinant adenoviruses Ad-U6-COX-2-shRNA-EGFP and Ad-U6-HK-EGFP were 1.4 × 10 12 and 2.0 × 10 12 pfu / ml respectively.The mRNA transcription and protein expression of COX-2 as well as proliferation ability of SMMC-7721 cells infected with Ad-U6-COX-2-shRNA-EGFP were significantly lower than those in blank and negative control groups(both P 0.05).Conclusion Recombinant adenovirus Ad-U6-COX-2-shRNA-EGFP was constructed successfully,which inhibited the proliferation of SMMC-7721 cells significantly.The study solved the problems in clinical application and laid a foundation of research on therapy of liver cancer as well as the relevant molecular mechanism.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To construct and identify the recombinant adenovirus with a short hairpin RNA(shRNA)targeting cyclooxygenase-2(COX-2),with a tag of enhanced green fluorescent protein(EGFP),and observe its effect on the proliferation of liver cancer SMMC-7721 cells.Methods The U6 expression promoter and shRNA sequences of previously constructed eukaryotic expression vector pGenesil-1-COX-2-shRNA and negative control plasmid pGenesil-1HK were subcloned into adenovirus shuttle plasmid pAdTrack.The constructed recombinant adenovirus shuttle plasmids pAdTrack-U6-COX-2-shRNA-EGFP and pAdTrack-U6-HK-EGFP were identified by enzyme digestion and DNA sequencing,then linearized with Pme Ⅰ and transformed to competent AdEasier.The obtained recombinant adenovirus plasmids pAd-U6-COX-2-shRNA-EGFP and pAd-U6-HK-EGFP were linearized with PacⅠ and transfected to AD293 cells for packaging.The obtained recombinant adenoviruses Ad-U6-COX-2-shRNA-EGFP and Ad-U6-HK-EGFP were subjected to three cycles of amplification and determined for titer.The mRNA transcription and protein expression of COX-2 in infected cells were determined by RT-PCR and Western blot.The effect of Ad-U6-COX-2-shRNA-EGFP on proliferation of SMMC-7721 cells was observed by MTS method.Results Recombinant adenovirus shuttle plasmids pAdTrack-U6-COX-2-shRNA-EGFP and pAdTrack-U6-HK-EGFP,as well as recombinant adenovirus plasmids pAd-U6-COX-2-shRNAEGFP and pAd-U6-HK-EGFP,were constructed correctly as proved by enzyme digestion and sequencing,and successfully transfected to AD293 cells.The titers of recombinant adenoviruses Ad-U6-COX-2-shRNA-EGFP and Ad-U6-HK-EGFP were 1.4 × 10 12 and 2.0 × 10 12 pfu / ml respectively.The mRNA transcription and protein expression of COX-2 as well as proliferation ability of SMMC-7721 cells infected with Ad-U6-COX-2-shRNA-EGFP were significantly lower than those in blank and negative control groups(both P 0.05).Conclusion Recombinant adenovirus Ad-U6-COX-2-shRNA-EGFP was constructed successfully,which inhibited the proliferation of SMMC-7721 cells significantly.The study solved the problems in clinical application and laid a foundation of research on therapy of liver cancer as well as the relevant molecular mechanism.

Key concepts: Recombinant DNA, Molecular biology, Small hairpin RNA, Plasmid, Transfection, Biology, Green fluorescent protein, Shuttle vector

Related papers

Back to paper searchBrowse research topicsOriginal source
Construction and identification of recombinant adenovirus with COX-2-shRNA — Research Paper | ScholarLens